C25.4 Código facturable y específico Malignant neoplasm of endocrine pancreas

ICD-10-CM C25.4 identifies “Malignant neoplasm of endocrine pancreas” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Capítulo 2: Neoplasms

Instrucciones del código

Inclusion terms1

Malignant neoplasm of islets of Langerhans

Use additional code1

code to identify any functional activity.

Instrucciones de niveles superiores

C25 · Malignant neoplasm of pancreas

Use additional code2
  • code to identify:
  • alcohol abuse and dependence (F10.-)
Code also1

if applicable exocrine pancreatic insufficiency (K86.81)

Capítulos 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C15-C26 · Malignant neoplasms of digestive organs (C15-C26)

Excludes 11

Kaposi's sarcoma of gastrointestinal sites (C46.4)

Excludes 21

gastrointestinal stromal tumors (C49.A-)

Referencias del índice oficial

Referencias del índice oficial (22)

Adenocarcinoma (2)
Carcinoma(malignant) (2)
Gastrinoma (2)
Glucagonoma (2)
Insulinoma (2)
Neoplasm, neoplastic (4)
Tumor (8)
Referencias desde otros códigos (3)
Historial

Historial del código

Último cambio registrado · FY2022

ModificadoSin cambios
FY2022

Vigente desde

  • Cambios en instrucciones heredadas

Malignant neoplasm of endocrine pancreas

Código de diagnóstico facturable

CDC/NCHS · FY2022

Todas las ediciones (19)

Todas las edicionesVigente desdeHistorial del código
FY20162015-10-01Primera aparición
FY20172016-10-01Cambios en instrucciones heredadas
FY20182017-10-01Sin cambios tabulares
FY20192018-10-01Sin cambios tabulares
FY20202019-10-01Sin cambios tabulares
FY2020 · April2020-04-01Sin cambios tabulares
FY20212020-10-01Sin cambios tabulares
FY2021 · 01-012021-01-01Sin cambios tabulares
FY20222021-10-01Cambios en instrucciones heredadas
FY2022 · 04-012022-04-01Sin cambios tabulares
FY20232022-10-01Sin cambios tabulares
FY2023 · 04-012023-04-01Sin cambios tabulares
FY20242023-10-01Sin cambios tabulares
FY2024 · 04-012024-04-01Sin cambios tabulares
FY20252024-10-01Sin cambios tabulares
FY2025 · 04-012025-04-01Sin cambios tabulares
FY20262025-10-01Sin cambios tabulares
FY2026 · April2026-04-01Sin cambios tabulares
FY20272026-10-01Sin cambios tabulares
Correspondencias históricas ICD-9 · 2018

Solo correspondencia histórica; no sustituye códigos automáticamente.

  • 157.4

Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.